IRIS
CIMMINO, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.160
NA - Nord America 1.688
AS - Asia 259
OC - Oceania 13
AF - Africa 9
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.140
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.673
IE - Irlanda 721
FR - Francia 358
IT - Italia 263
GB - Regno Unito 262
UA - Ucraina 226
CN - Cina 137
DE - Germania 98
GR - Grecia 79
TR - Turchia 63
FI - Finlandia 55
SE - Svezia 47
BE - Belgio 15
ID - Indonesia 15
KR - Corea 11
AU - Australia 10
NL - Olanda 9
CA - Canada 7
ES - Italia 7
IN - India 7
MX - Messico 7
BR - Brasile 6
VN - Vietnam 6
IR - Iran 5
PL - Polonia 5
AT - Austria 3
EU - Europa 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
SG - Singapore 3
ZA - Sudafrica 3
BG - Bulgaria 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
EG - Egitto 2
HK - Hong Kong 2
NO - Norvegia 2
PT - Portogallo 2
RO - Romania 2
TW - Taiwan 2
BF - Burkina Faso 1
CO - Colombia 1
CR - Costa Rica 1
EC - Ecuador 1
IL - Israele 1
MA - Marocco 1
MY - Malesia 1
NA - Namibia 1
NG - Nigeria 1
PH - Filippine 1
RS - Serbia 1
RU - Federazione Russa 1
Totale 4.140
Salva come PNG Salva come JPEG
Città #
Dublin 718
Jacksonville 377
Chandler 267
Princeton 99
Roxbury 91
Medford 78
Ann Arbor 75
Naples 54
Wilmington 52
Beijing 44
Des Moines 34
Woodbridge 33
Cambridge 29
Nanjing 27
Boardman 26
Düsseldorf 26
Bremen 22
Ashburn 18
Brussels 15
New York 15
Jinan 14
Redwood City 13
San Mateo 12
Houston 11
Mountain View 11
Napoli 11
Auburn Hills 10
Caserta 9
Norwalk 9
Amsterdam 7
Birmingham 7
Nanchang 7
Blackheath 6
Dong Ket 6
Shenyang 6
Tianjin 6
Jakarta 5
Los Angeles 5
Ningbo 5
Gunzenhausen 4
Helsinki 4
Montesarchio 4
Mount Juliet 4
Osimo 4
Rome 4
San Nicola la Strada 4
Seattle 4
Sennori 4
Venice 4
Auckland 3
Bellefonte 3
Camerino 3
Casalnuovo di Napoli 3
Changsha 3
Fairfield 3
Hangzhou 3
Johannesburg 3
Lodz 3
London 3
Marano Di Napoli 3
Milan 3
North Wales 3
Piscataway 3
San Prisco 3
Udine 3
Valencia 3
Vienna 3
Berlin 2
Boisar 2
Buffalo 2
Chongqing 2
Dalmine 2
Giugliano In Campania 2
Grenoble 2
Guangzhou 2
Hackensack 2
Haikou 2
Hanover 2
Hebei 2
Hong Kong 2
Hyderabad 2
Karachi 2
Lanzhou 2
Lucca 2
Madinat Hamad 2
Magelang 2
Manchester 2
Menlo Park 2
Mereto Di Tomba 2
Montichiari 2
Mérida 2
Ottawa 2
Padova 2
Pozzuoli 2
Pune 2
Ramsis 2
Rio De Janeiro 2
Salerno 2
Santa Maria Capua Vetere 2
Taiyuan 2
Totale 2.420
Salva come PNG Salva come JPEG
Nome #
The Two Faces of Thrombosis: Coagulation Cascade and Platelet Aggregation. Are Platelets the Main Therapeutic Target? 297
C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes. 100
Activation by ADP modulates miRNA expression profile in platelets. new insights into the pathophysiology of platelet activation 81
Activating stimuli induce platelet microRNA modulation and proteome reorganisation 80
Transcoronary Th-17 lymphocytes and acute coronary syndromes: new evidence from the crime scene? 76
Genesis and dynamics of atherosclerotic lesions: Implications for early detection 66
Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: evidence for a local, intracoronary immunologic mechanism. 65
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation 65
A Fatal Case of Endocarditis on CoreValve ReValving System Caused by Enterococcus faecium Complicated by Iatrogenic Pancytopenia and Subacute Disseminated Intravascular Coagulation 63
The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion 62
The treatment of acute myocardial infarction in 2017 61
Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: Limitations of a commercial assay 60
Adeno-associated virus serotype 8 ApoA-I gene transfer reduces progression of atherosclerosis in ApoE-KO Mice: Comparison of intramuscular and intravenous administration 58
C-reactive protein induces expression of matrix metalloproteinase-9: A possible link between inflammation and plaque rupture. 58
Safe and sustained overexpression of functional apolipoprotein a-i/high-density lipoprotein in apolipoprotein a-i-null mice by muscular adeno-associated viral serotype 8 vector gene transfer 56
Myocardial reperfusion injury 54
Atherothrombosis: role of tissue factor; link between diabetes, obesity and inflammation 53
The adipokine apelin-13 induces expression of prothrombotic tissue factor 53
New antithrombotic drugs in cardiovascular disease 53
Rapid Change in Plaque Size, Composition, and Molecular Footprint After Recombinant Apolipoprotein A-IMilano (ETC-216) Administration. Magnetic Resonance Imaging Study in an Experimental Model of Atherosclerosis 53
Evolving Concepts in LDL-Lowering Strategies: Are We There? 52
Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population 52
Oxidative stress within the coronary circulation is associated with reduction in endothelium-dependent coronary vasodilation in patients with acute coronary syndromes. 51
Carvedilol administration in acute myocardial infarction results in stronger inhibition of early markers of left ventricular remodeling than metoprolol 51
Acute ApoA-I Milano administration induces plaque regression and stabilisation in the long term 50
Upregulation of TH/IL-17 Pathway-Related Genes in Human Coronary Endothelial Cells Stimulated with Serum of Patients with Acute Coronary Syndromes 50
Immune-inflammatory activation in acute coronary syndromes: A look into the heart of unstable coronary plaque 50
Targeting tissue factor as an antithrombotic strategy 48
Contrast-enhanced ultrasound imaging detects intraplaque neovascularization in an experimental model of atherosclerosis 47
Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-I Milano 47
High-density lipoproteincholesterol, reverse cholesterol transport, and cardiovascular risk: a tale of genetics? 46
Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit model 46
Colchicine reduces platelet aggregation by modulating cytoskeleton rearrangement via inhibition of cofilin and LIM domain kinase 1 46
Quantification of serial changes in plaque burden using multi-detector computed tomography in experimental atherosclerosis 45
Splicing of platelet resident pre-mRNAs upon activation by physiological stimuli results in functionally relevant proteome modifications 45
Role of tissue factor pathway inhibitor in the regulation of tissue factor-dependent blood coagulation 43
High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need 43
Expression of functional tissue factor in activated T-lymphocytes in vitro and in vivo: A possible contribution of immunity to thrombosis? 42
How can we explore atherosclerotic plaque composition and regression? 41
Platelet biology and receptor pathways. 40
Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: An magnetic resonance imaging study in a model of advanced atherosclerosis 40
Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: Analysis of ischemic myocardium at risk using cardiac magnetic resonance 40
Pregnancy-Associated Plasma Protein-A and its Role in Cardiovascular Disease. Biology, Experimental/Clinical Evidences and Potential Therapeutic Approaches 40
Antiplatelet therapy for non-ST-Segment elevation myocardial infarction in complex "real" Clinical Scenarios: A Consensus Document of the "campania NSTEMI Study Group" 40
Local cytokine production in patients with Acute Coronary Syndromes: a look into the eye of the perfect (cytokine) storm. 39
Oxygen free radicals induce a procoagulant state in endothelial cells by inhibiting tissue-factor pathway inhibitor 39
Reactive oxygen species induce a procoagulant state in endothelial cells by inhibiting tissue factor pathway inhibitor 39
Role of circulating factors in cardiac aging 38
Antiplatelet therapy in Acute Coronary Syndromes. Lights and shadows of platelet function tests to guide the best therapeutic approach 38
Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation. 37
Pathophysiology of Vulnerability Caused by Thrombogenic (Vulnerable) Blood 37
Nobiletin inhibits oxidized-LDL mediated expression of Tissue Factor in human endothelial cells through inhibition of NF-kappa B 37
The nuclear receptor ER beta engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading 37
Decreased Blood-Borne Tissue Factor Activity in Patients Presenting With Acute Coronary Syndrome: Should the Old Paradigm be Revisited? 36
Secretory phospholipase A(2) type IIA levels are increased in the coronary circulation of patients with acute coronary syndromes 35
Recombinant HDL Milano exerts greater anti-inflammatory and plaque stabilizing properties than HDL wild-type 35
Role of Tissue Factor in the Coagulation Network 35
Cognitive Function and Atrial Fibrillation: From the Strength of Relationship to the Dark Side of Prevention. Is There a Contribution from Sinus Rhythm Restoration and Maintenance? 35
Expansion of Th17 cells and IL-17 are present only in a subset of patients with acute coronary syndrome 34
Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited? 33
Relationship between Pregnancy-associated Plasma Protein-A and tissue factor levels in the coronary circulation of patients with acute coronary syndrome 33
Voltage-directed cavo-tricuspid isthmus ablation using a novel ablation catheter mapping technology in a myotonic dystrophy type i patient 33
Tissue factor: newer concepts in thrombosis and its role beyond thrombosis and hemostasis 33
Oxidized Low-Density Lipoproteins Induce Tissue Factor Expression in T-Lymphocytes via activation of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 33
Prognostic Factors in Patients With Stemi Undergoing Primary PCI in the Clopidogrel Era: Role of Dual Antiplatelet Therapy at Admission and the Smoking Paradox on Long-Term Outcome 32
The role of the atrial electromechanical delay in predicting atrial fibrillation in beta-thalassemia major patients 32
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry 32
The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor? 31
The complex puzzle underlying the pathophysiology of acute coronary syndromes: from molecular basis to clinical manifestations. 30
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: Insights from the GARFIELD-AF registry 30
Lipid Target in Very High-Risk Cardiovascular Patients: Lesson from PCSK9 Monoclonal Antibodies 29
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry 29
Cardiovascular comorbidities and pharmacological treatments of covid-19 patients not requiring hospitalization 29
Myotonic dystrophy type 1 and pulmonary embolism: successful thrombus resolution with dabigatran etexilate therapy 27
The cardiac paradox of losing weight: a case of gastro-cardiac syndrome 25
An unusual case of retrobulbar haemorrhage following a transoesophageal echocardiogram: a rare but a potential severe complication 24
Time trends in antithrombotic management of patients with atrial fibrillation treated with coronary stents: Results from TALENT-AF (The internAtionaL stENT – Atrial Fibrillation study) multicenter registry 24
Colchicine inhibits the prothrombotic effects of oxLDL in human endothelial cells 24
Asymptomatic Stroke in the Setting of Percutaneous Non-Coronary Intervention Procedures 24
Effects of Hypobaric Hypoxia on Endothelial Function and Adiponectin Levels in Airforce Aviators 23
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation 23
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation 23
Pathophysiology and mechanisms of Acute Coronary Syndromes: atherothrombosis, immune-inflammation, and beyond 23
Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists 21
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 21
Radial pseudoaneurysm in elderly: A rare event with undefined therapeutical approach. A case report and literature review 20
Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry 20
Role of Cardiac Biomarkers in Non-Small Cell Lung Cancer Patients 20
Safety of transesophageal echocardiogram in anticoagulated patients 20
Effectiveness in the short-term of a novel nutraceutical for the management of hypercholesterolemia: an observational multicenter primary care experience 19
Improved risk stratification of patients with atrial fibrillation: An integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation 19
TAKOTSUBO CARDIOMYOPATHY AS EPIPHENOMENON OF CARDIOTOXICITY IN CANCER PATIENTS: A META SUMMARY OF CASE REPORTS 19
Current Views on Infective Endocarditis: Changing Epidemiology, Improving Diagnostic Tools and Centering the Patient for Up-to-Date Management 19
Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel 17
Two-year outcomes of patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 16
Peripheral artery disease and abdominal aortic aneurysm: The forgotten diseases in covid-19 pandemic. results from an observational study on real-world management 16
Impact of gender on event rates at 1-year in patients with newly diagnosed non-valvular atrial fibrillation: Contemporary perspective from the GARFIELD-AF registry 15
Vitamin D inhibits Tissue Factor and CAMs expression in oxidized low-density lipoproteins-treated human endothelial cells by modulating NF-κB pathway 15
Percutaneous Left Atrial Appendage Occlusion: An Emerging Option in Patients with Atrial Fibrillation at High Risk of Bleeding 15
Effects of colchicine on tissue factor in oxLDL-activated T-lymphocytes 15
Totale 4.146
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.004
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.004
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201910 0 0 0 0 0 0 0 0 0 0 8 2
2019/2020746 181 108 72 8 70 23 106 31 25 49 55 18
2020/2021585 27 9 61 72 75 13 96 51 6 60 89 26
2021/2022645 25 16 33 15 214 10 13 14 22 34 50 199
2022/20231.214 127 22 24 81 91 76 6 70 631 34 29 23
2023/2024487 50 30 38 58 223 25 19 20 5 16 3 0
Totale 4.335